IPO STREAM
Your weekly guide to the IPO market
Week of April 6–10, 2026 | Free Edition
Big news: SpaceX reportedly confidentially filed for an initial public offering (IPO) with the SEC on April 1. It could be the largest listing in history, with a potential listing window as early as June.
This Week in IPOs: April 6–10, 2026
It is a busy week on the IPO calendar — and a turbulent one in the broader markets. Six offerings are slated to price or begin trading this week, ranging from a modest $6 million digital marketing uplisting all the way to Metals Royalty Co.'s $275.5 million NASDAQ Capital Market Direct Listing; the week's marquee transaction by implied deal size, and by far its most complex in structure.
A note on timing: two offerings this week have had winding roads to market. Optimi Health Ltd. (OPTH) was originally scheduled for the week of March 30, 2026 and has been pushed to this week. TV Channels Network (TVCN) has a more eventful history: the company originally filed its S-1 on January 31, 2025, filed a withdrawal letter with the SEC on April 17, 2025, re-filed on May 2, 2025, and is now attempting to price more than a year after its initial filing.
Hillhouse Frontier Holdings (HIFI) was originally expected to trade the week of February 16, 2026, and also arrives late. These histories are context that investors should factor into their assessment.
This Week's IPO & Listing Calendar
Market Volatility Exposes Weak Delegation
When markets get shaky, advisors don’t just manage portfolios. They manage fear, questions, follow-up and a flood of client communication.
That’s where weak delegation gets expensive.
If meeting prep, paperwork, CRM updates and account admin still run through you, response times slip and the client experience takes the hit.
BELAY created the free Financial Advisor’s Delegation Guide to help you identify what to hand off, what to keep and how to stay client-facing without losing control.
Inside, you’ll learn how to reduce bottlenecks, protect responsiveness and free up more time for the work only you should be doing.

Sources: IPOScoop.com; SEC EDGAR filings. TMCR: Direct Listing — reference price $5.00; no new capital raised by the company. All NASDAQ listings above are on the NASDAQ Capital Market except BWGC (NASDAQ Global Market).
Unlock the Full Analysis — IPO Stream Premium
Free subscribers get the overview. Premium subscribers get the edge — grades, price targets, scorecards, and a plain-English verdict on every deal. Every week.
IPO Letter Grade (A–F): Our overall buy/avoid rating built on 8 scored categories
8-Category Investment Scorecard: Business Quality, Moat, Revenue Growth, Governance, Valuation, Deal Structure, Sector Timing, and Macro Risk — each scored and explained
IPO-Day Limit Order Strategy: Aggressive, Moderate, Conservative, and Avoid/Watch entry price targets with position-sizing guidance
1-Year Price Probability Analysis: Bull, Base, Flat, and Bear scenarios with probability-weighted 12-month price target
Full Bull & Bear Case, Deep Financial Analysis, Comparable Company Valuation, and our Plain-English Bottom Line
Upgrade to IPO Stream Premium — get the full scorecard, price targets, and bottom-line verdict on every deal.
BW Industrial Holdings (BWGC)
S-1 Filing: View on SEC EDGAR | Lead Manager: Eddid Securities USA | NASDAQ Global Market: BWGC
What Do They Do?
BW Industrial Holdings is a Houston-based engineering, procurement, and construction (EPC) company that builds sophisticated manufacturing facilities for clients in the energy storage, battery manufacturing, electronics, automotive parts, and semiconductor industries. The company operates through its wholly owned subsidiary Bestwater USA Inc. (d/b/a BW Industrial Construction), a Texas corporation. BW Industrial Holdings Inc. itself was incorporated in Delaware in April 2025. The company was founded in 2016 and has 18 full-time employees.
The IPO at a Glance
Ticker / Exchange | BWGC / NASDAQ Global Market |
IPO Price Range | $7.00 – $9.00 (midpoint: $8.00) |
Shares Offered | 2,625,000 shares |
Est. Deal Size | ~$21.0 million (at $8.00 midpoint) |
Market Cap (midpoint) | ~$176 million |
FY2023 Revenue | $29.1 million (disclosed in S-1) |
FY2024 Revenue | $102.0 million (disclosed in S-1; +251% YoY) |
9M 2025 Revenue | $19.9 million (vs $66.3M in 9M 2024; approx. –70% YoY) |
LTM Revenue | ~$55.6M (derived: FY2024 minus 9M2024 plus 9M2025) |
LTM Net Income | ~$7.6M (derived same method) |
Incorporation | Delaware (BW Industrial Holdings Inc.); Texas (Bestwater USA Inc.) |
Employees | 18 full-time | Founded: 2016 |
S-1 Filed | December 30, 2025 |
Financial Overview

All figures sourced from BW Industrial Holdings S-1 filed December 30, 2025. LTM (trailing twelve months to September 30, 2025) is a derived figure: FY2024 revenue of $102.0M minus nine months ended September 30, 2024 ($66.3M) plus nine months ended September 30, 2025 ($19.9M) = $55.6M. This figure is not separately stated in the S-1.
The financial picture here is nuanced and investors must look at both the annual figures and the most recent nine-month period together.
Customer concentration is also a critical consideration. In FY2024, two clients accounted for 78% and 19% of revenue, respectively. This means 97% of revenue came from just two clients. In FY2023, a single client represented 96% of revenue. This is extreme concentration for any public company.
The Investment Thesis — In Plain English
The bull case for BWGC centers on sector timing: the U.S. is in the early innings of a multi-decade reshoring wave, and companies that build advanced manufacturing facilities are well-positioned. BW Industrial has demonstrated it can win large, complex projects and execute them profitably.
The bear case is concentration, lumpy revenue, and valuation. With 18 employees and 97% of FY2024 revenue from just two clients, the business is a high-dependency operation.
Want the IPO-Day Limit Order Strategy, full Scorecard, and 1-Year Price Target for BWGC? That's in IPO Stream Premium.
Optimi Health Ltd. (OPTH) ★ Rescheduled from March 30
F-1/A Filing: View on SEC EDGAR | Lead Manager: Joseph Gunnar & Co. | NASDAQ Capital Market: OPTH
⚑ Originally scheduled for the week of March 30, 2026. Rescheduled to this week.
What Do They Do?
Optimi Health Corp. is a British Columbia-incorporated, Health Canada-licensed pharmaceutical manufacturer that produces GMP-grade MDMA and botanical psilocybin for use in mental health therapies.
This is NOT a traditional IPO. Optimi already trades on the Canadian Securities Exchange (CSE: OPTI), the OTCQX Market (OPTHF), and the Frankfurt Stock Exchange (8BN). This offering is a NASDAQ uplisting — 2.5 million newly issued shares at $6.00–$8.00 per share to raise approximately $17.5 million at the midpoint.
The IPO at a Glance
Ticker / Exchange | OPTH / NASDAQ Capital Market (Uplisting) |
Offering Price Range | $6.00 – $8.00 (midpoint: $7.00) |
Shares Offered | 2.5 million shares |
Est. Deal Size | ~$17.5 million (at midpoint) |
Market Cap | ~$28.6 million |
Revenue (LTM) | $0.31 million (year ended Sept. 30, 2025) |
Net Loss (LTM) | $2.67 million (year ended Sept. 30, 2025) |
Employees | 10 | Founded: 2020 |
Incorporation | British Columbia, Canada |
Current Markets | Australia (commercial); Canada (Special Access Program) |
Rescheduled from | Week of March 30, 2026 |

The opportunity here is optionality, not current fundamentals. Optimi's LTM revenue is $310,000. The investment thesis rests entirely on the expansion of regulated psychedelic-assisted therapy into new markets, particularly the United States, where MDMA and psilocybin remain Schedule I controlled substances.
For the speculative investor with a long time horizon and high risk tolerance, Optimi offers genuine upside exposure to a sector that has real regulatory momentum in Australia and Canada.
IPO Stream Premium members get the full grade, scorecard, and IPO-day strategy for OPTH.
The Key to This $240B Market Is in Your Bloodstream
Every year, $240B is spent on treating the symptoms of osteoarthritis, yet not a single therapy has stopped it. Cytonics not only discovered why, they found an answer hiding inside the human body all along. Their first-generation therapy has already treated 10,000+ patients. Now they're pushing a 200% more potent version toward FDA approval. Claim a piece as an early-stage investor today.
Metals Royalty Co. (TMCR) — NASDAQ Direct Listing
Prospectus (F-1): View on SEC EDGAR | Financial Advisor: Stifel | NASDAQ Capital Market: TMCR | Expected: April 8, 2026
What Do They Do? (And What Is a Direct Listing?)
Metals Royalty Co. is a Calgary, Alberta-based royalty acquisition company focused on critical metals and minerals. Its sole asset is the NORI Royalty — a 2.0% gross overriding royalty on the NORI Property, a polymetallic nodule project being developed by The Metals Company (TMC, a separate publicly traded company) in the Clarion-Clipperton Zone of the northeastern Pacific Ocean. The area does not yet have a commercial production permit from the International Seabed Authority (ISA). Metals Royalty has not received any royalty revenue from this asset to date.
This is a Direct Listing, not a traditional IPO.
The Listing at a Glance
Ticker / Exchange | TMCR / NASDAQ Capital Market (Direct Listing — April 8, 2026) |
Reference Price | $5.00 per share (Dec. 2025 private placement price) |
Shares Offered | Up to 55.1 million (by existing shareholders) |
New Capital Raised | None — the company receives $0 from this listing |
Implied Market Cap | ~$215.5 million at $5.00 |
Revenue (LTM) | $0 — development stage; no royalty income received to date |
Net Loss (LTM) | $1.18 million (12 months ended Sept. 30, 2025) |
Incorporation | British Columbia, Canada | Founded: 2022 |
Sole Asset | NORI Royalty: 2.0% gross overriding royalty on NORI Property |
ISA Permit Status | Not yet granted — no commercial production permitted |
Financial Advisor | Stifel (financial advisor only — not an underwriter) |
Metals Royalty is the week's largest transaction by implied deal size, and its highest-risk by nearly every measure. However, the critical minerals tailwind is real. Governments worldwide are competing to secure supply chains for nickel, cobalt, copper, and manganese, all present in polymetallic nodules in the NORI Property.
Premium subscribers get the TMCR Scorecard, full Bull & Bear cases, and our Plain-English bottom-line verdict.
The Micro-Cap Trio: HIFI, HFUS, and TVCN
Hillhouse Frontier Holdings (HIFI)
S-1 Filing: View on SEC EDGAR | Lead: Cathay Securities | Price: $4–$6 | Originally expected Feb. 16, 2026
Hillhouse Frontier Holdings is a Nevada-incorporated luxury vehicle exporter that purchases premium U.S. vehicles and ships them to Hong Kong for redistribution into mainland China. The company was founded in 2022, operates with just three employees, and generated $7.19 million in LTM revenue with $320,000 in net income.
It is raising up to $18.8 million at a $4–$6 price range, implying a market cap of approximately $118.8 million at the $5 midpoint; a price-to-sales ratio of approximately 16.5x on a three-employee company with a single Hong Kong distribution client.
Hartford Creative Group (HFUS) — Uplisting
S-1/A Filing: View on SEC EDGAR | Lead: WestPark Capital | Price: $4.00 fixed | OTC uplisting — NOT a new IPO
Hartford Creative Group is a digital marketing firm serving small and medium-sized businesses in China via social media and influencer marketing platforms. It is uplisting from OTC Markets to NASDAQ Capital Market — offering 1.5 million shares at $4.00 to raise $6.0 million.
The company's own prospectus discloses material risk: it warns that its China ties "could materially hinder or prevent our offering of securities to investors and cause the value of such securities to significantly decline or be worthless."
TV Channels Network (TVCN) — Re-Filed
S-1 Filing: View on SEC EDGAR | Lead: Craft Capital Management | Price: $4.00 fixed | Founded 2022
TV Channels Network is a Las Vegas-based streaming and music entertainment company with one employee, zero revenue, a net loss of $160,000, and a proposed market cap of $179.4 million at $4.00 per share. The company was founded in 2022 and intends to offer 100 live linear concert channels and on-demand content.
Have a good week,
Tim Fields
Get the Full Picture with IPO Stream Premium
This free edition gives you the landscape. IPO Stream Premium gives you the full map: grades, price targets, limit order strategies, scorecards, and a direct verdict on every deal — every week.
IPO Letter Grade (A–F) built on 8 scored categories
IPO-Day Limit Order Strategy with exact entry price targets by investor profile
1-Year Price Probability Analysis with Bull, Base, Flat, and Bear scenarios
Comparable Company Valuation, Deep Financial Analysis, and Full Bull & Bear Cases
Plain-English Bottom Line: buy, watch, or avoid — and exactly why
Upgrade to IPO Stream Premium today and get the full analysis every week.



